Alberto Lleó

42.9k total citations · 1 hit paper
224 papers, 7.6k citations indexed

About

Alberto Lleó is a scholar working on Physiology, Psychiatry and Mental health and Neurology. According to data from OpenAlex, Alberto Lleó has authored 224 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 137 papers in Physiology, 71 papers in Psychiatry and Mental health and 57 papers in Neurology. Recurrent topics in Alberto Lleó's work include Alzheimer's disease research and treatments (131 papers), Dementia and Cognitive Impairment Research (70 papers) and Parkinson's Disease Mechanisms and Treatments (24 papers). Alberto Lleó is often cited by papers focused on Alzheimer's disease research and treatments (131 papers), Dementia and Cognitive Impairment Research (70 papers) and Parkinson's Disease Mechanisms and Treatments (24 papers). Alberto Lleó collaborates with scholars based in Spain, United States and United Kingdom. Alberto Lleó's co-authors include Jordi Clarimón, Daniel Alcolea, Juan Fortea, Rafael Blesa, John H. Growdon, Steven M. Greenberg, José Luís Molinuevo, Bradley T. Hyman, Oksana Berezovska and Olivia Belbin and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Nature Communications.

In The Last Decade

Alberto Lleó

215 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease

2024 140 citations Juan Fortea, Jordi Pegueroles et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alberto Lleó Spain	48	4.1k	2.3k	1.8k	1.6k	1.3k	224	7.6k
Kristel Sleegers Belgium	49	4.2k 1.0×	2.9k 1.3×	1.6k 0.9×	1.3k 0.8×	1.4k 1.1×	135	7.4k
James J. Lah United States	59	4.5k 1.1×	4.1k 1.7×	1.0k 0.6×	1.2k 0.8×	1.7k 1.3×	204	9.4k
Qiao‐Xin Li Australia	48	4.7k 1.1×	2.5k 1.1×	1.3k 0.7×	1.1k 0.7×	992 0.8×	144	8.0k
Miloš D. Ikonomović United States	50	4.8k 1.2×	2.5k 1.1×	1.6k 0.9×	2.3k 1.4×	1.6k 1.2×	162	9.0k
Meng‐Shan Tan China	49	3.6k 0.9×	2.7k 1.2×	846 0.5×	1.7k 1.1×	2.5k 1.9×	127	9.3k
Lucia I. Sue United States	53	5.1k 1.2×	2.3k 1.0×	3.9k 2.1×	1.6k 1.0×	2.1k 1.6×	127	9.9k
Erik Portelius Sweden	52	6.4k 1.5×	3.6k 1.5×	1.2k 0.7×	2.8k 1.7×	1.5k 1.2×	144	9.2k
Paul Edison United Kingdom	41	5.0k 1.2×	2.4k 1.0×	2.0k 1.1×	2.0k 1.2×	3.7k 2.8×	104	10.5k
Niels Andreasen Sweden	55	6.4k 1.5×	3.0k 1.3×	1.5k 0.8×	3.7k 2.3×	1.7k 1.3×	120	9.8k
Tuula Pirttilä Finland	45	4.2k 1.0×	1.9k 0.8×	1.2k 0.7×	2.8k 1.8×	1.4k 1.0×	119	7.6k

Countries citing papers authored by Alberto Lleó

Since Specialization

Citations

This map shows the geographic impact of Alberto Lleó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Lleó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Lleó more than expected).

Fields of papers citing papers by Alberto Lleó

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alberto Lleó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Lleó. The network helps show where Alberto Lleó may publish in the future.

Co-authorship network of co-authors of Alberto Lleó

This figure shows the co-authorship network connecting the top 25 collaborators of Alberto Lleó. A scholar is included among the top collaborators of Alberto Lleó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alberto Lleó. Alberto Lleó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rubio‐Guerra, Sara, Sara Bernal, Valle Camacho, et al.. (2025). A Novel CHMP2B Splicing Variant in Atypical Presentation of Familial Frontotemporal Lobar Degeneration. Annals of Clinical and Translational Neurology. 12(9). 1894–1900. 1 indexed citations

Tzortzakakis, Antonios, Javier Arranz, Víctor Montal, et al.. (2025). Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum. Brain Communications. 7(3). fcaf173–fcaf173. 1 indexed citations

Vermunt, Lisa, Carel F.W. Peeters, Emma L. van der Ende, et al.. (2025). Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia. Molecular Neurodegeneration. 20(1). 93–93. 1 indexed citations

Barba, Lorenzo, Giovanni Bellomo, Daniel Alcolea, et al.. (2025). Serum level changes of the synaptic marker beta-synuclein in Alzheimer’s disease continuum and other dementias. Journal of Neurology Neurosurgery & Psychiatry. 96(12). jnnp–2025.

Alcolea, Daniel, Laia Montoliu‐Gaya, María Carmona‐Iragui, et al.. (2024). Longitudinal plasma and CSF analyses in Down syndrome. Results from the DABNI cohort. Alzheimer s & Dementia. 20(S2).

Fortea, Juan, Jordi Pegueroles, Daniel Alcolea, et al.. (2024). APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease. Nature Medicine. 30(5). 1284–1291. 140 indexed citations breakdown →

Gordoa, Javier Sánchez‐Ruiz de, Iván Méndez-López, Miren Roldán, et al.. (2023). Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease. Neurology. 101(23). e2434–e2447. 9 indexed citations

Lleó, Alberto, Daniel Alcolea, Afina W. Lemstra, et al.. (2023). Thimet oligopeptidase as a potential CSF biomarker for Alzheimer's disease: A cross‐platform validation study. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 15(3). e12456–e12456. 8 indexed citations

Goossens, Julie, Juan Fortea, Daniel Alcolea, et al.. (2023). Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum. Alzheimer s Research & Therapy. 15(1). 186–186. 11 indexed citations

10.

Campo, Marta del, Lisa Vermunt, Carel F.W. Peeters, et al.. (2023). CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease. Nature Communications. 14(1). 5635–5635. 31 indexed citations

11.

Pegueroles, Jordi, Víctor Montal, Alexandre Bejanin, et al.. (2021). AMYQ: An index to standardize quantitative amyloid load across PET tracers. Alzheimer s & Dementia. 17(9). 1499–1508. 14 indexed citations

12.

Kort, Anna M. de, H. Bea Kuiperij, Daniel Alcolea, et al.. (2021). Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy. Alzheimer s Research & Therapy. 13(1). 160–160. 6 indexed citations

13.

Dols‐Icardo, Oriol, Víctor Montal, Sònia Sirisi, et al.. (2020). Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Neurology Neuroimmunology & Neuroinflammation. 7(5). 57 indexed citations

14.

Benejam, Bessy, Laura Videla, Eduard Vilaplana, et al.. (2020). Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 12(1). e12047–e12047. 31 indexed citations

15.

Lehmann, Sylvain, Julien Dumurgier, Xavier Ayrignac, et al.. (2020). Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals. Alzheimer s Research & Therapy. 12(1). 123–123. 40 indexed citations

16.

Carmona‐Iragui, María, Laura Videla, Alberto Lleó, & Juan Fortea. (2019). Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis. Developmental Neurobiology. 79(7). 716–737. 38 indexed citations

17.

Fissolo, Nicolás, Laura Cervera‐Carles, Alberto Lleó, et al.. (2018). Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis. Multiple Sclerosis Journal. 25(11). 1535–1538. 9 indexed citations

18.

Alcolea, Daniel, Eduard Vilaplana, Marc Suárez‐Calvet, et al.. (2017). CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration. Neurology. 89(2). 178–188. 92 indexed citations

19.

Valero, Jorge, Alfredo J. Miñano‐Molina, Roser Masgrau, et al.. (2010). -Amyloid Disrupts Activity-Dependent Gene Transcription Required for Memory through the CREB Coactivator CRTC1. Journal of Neuroscience. 30(28). 9402–9410. 100 indexed citations

20.

Lleó, Alberto, Elaine Waldron, Christine A. F. Von Arnim, et al.. (2005). Low Density Lipoprotein Receptor-related Protein (LRP) Interacts with Presenilin 1 and Is a Competitive Substrate of the Amyloid Precursor Protein (APP) for γ-Secretase. Journal of Biological Chemistry. 280(29). 27303–27309. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact